UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

NRF2 Activation in Cancer: From DNA to Protein

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (5), p.889-898

2019

Volltextzugriff (PDF)

SWI/SNF chromatin remodeling complexes and cancer

American journal of medical genetics. Part C, Seminars in medical genetics, 2014-09, Vol.166C (3), p.350-366

2014

Volltextzugriff (PDF)

ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas

PloS one, 2024-02, Vol.19 (2), p.e0297741-e0297741

2024

Volltextzugriff (PDF)

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

Clinical cancer research, 2020-08, Vol.26 (15), p.3908-3917

2020

Volltextzugriff (PDF)

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

The Journal of pathology, 2016-02, Vol.238 (3), p.389-400

2016

Volltextzugriff (PDF)

The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type

The Journal of pathology, 2017-07, Vol.242 (3), p.371-383

2017

Volltextzugriff (PDF)

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition

Clinical cancer research, 2018-04, Vol.24 (8), p.1932-1943

2018

Volltextzugriff (PDF)

Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss

Nature communications, 2023-05, Vol.14 (1), p.2894-2894, Article 2894

2023

Volltextzugriff (PDF)

SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development

Molecular cancer research, 2014-11, Vol.12 (11), p.1574-1585

2014

Volltextzugriff (PDF)

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

Oncotarget, 2015-02, Vol.6 (5), p.3165-3177

2015

Volltextzugriff (PDF)

Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene

Epigenetics, 2011-12, Vol.6 (12), p.1444-1453

2011

Volltextzugriff (PDF)

SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (9), p.3542-3547

2005

Volltextzugriff (PDF)

BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest

Journal of cellular physiology, 2011-08, Vol.226 (8), p.1989-1997

2011

Volltextzugriff (PDF)

SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression

The American journal of pathology, 2023-04, Vol.193 (4), p.456-473

2023

Volltextzugriff (PDF)

Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities

Expert review of anticancer therapy, 2019-05, Vol.19 (5), p.375-391

2019

Volltextzugriff (PDF)

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2767-2779

2018

Volltextzugriff (PDF)

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

The EMBO journal, 1999-07, Vol.18 (14), p.3990-4003

1999

Volltextzugriff (PDF)

Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression

Oncogene, 2002-02, Vol.21 (8), p.1196-1207

2002

Volltextzugriff (PDF)

SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters

Molecular cancer research, 2013-03, Vol.11 (3), p.251-260

2013

Volltextzugriff (PDF)

Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor

Journal of cell science, 2020-07, Vol.133 (14)

2020

Volltextzugriff (PDF)

TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice

Oncogene, 2022-06, Vol.41 (25), p.3423-3432

2022

Volltextzugriff (PDF)

Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type

Clinical cancer research, 2020-08, Vol.26 (16), p.4402-4413

2020

Volltextzugriff (PDF)

Reexpression of hSNF5 in Malignant Rhabdoid Tumor Cell Lines Causes Cell Cycle Arrest through a p21CIP1/WAF1-Dependent Mechanism

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (5), p.1854-1865

2010

Volltextzugriff (PDF)

A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue

The Journal of pathology, 2020-10, Vol.252 (2), p.125-137

2020

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(158)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Humans
(96)
Life Sciences & Biomedicine
(91)
Animals
(55)
Oncology
(50)
Biological And Medical Sciences
(45)
Mice
(41)
Tumor Cells, Cultured
(33)
Tumors
(28)
Medical Sciences
(27)
Biochemistry & Molecular Biology
(25)
Cell Biology
(25)
Transcription Factors - Genetics
(22)
Transcription Factors - Metabolism
(22)
Female
(21)
Cell Line, Tumor
(20)
Base Sequence
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Gene Expression Regulation, Neoplastic
(17)
Hybrid Cells
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

NRF2 Activation in Cancer: From DNA to Protein

SWI/SNF chromatin remodeling complexes and cancer

ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition

Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss

SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development

Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene

SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation

BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest

SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression

Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression

SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters

Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor

TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice

Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type

Reexpression of hSNF5 in Malignant Rhabdoid Tumor Cell Lines Causes Cell Cycle Arrest through a p21CIP1/WAF1-Dependent Mechanism

A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue

Suchergebnisse filtern